Shenzhen KangNing Hospital

Futó vizsgálatok

• Toboroz

  A Study of Brenipatide in Participants With Alcohol Use Disorder

  NCT07219953· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

  NCT07219966· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  NCT07011732· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Még nem toboroz

  Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism

  NCT05947162· Shenzhen Kangning Hospital· Forrás

• Toboroz

  Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

  NCT05980949· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Alzheimer-kór3 toboroz
• Skizofrénia1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Phase II Study to Evaluate NH102 for Depression

  NCT06842992· 2. fázis· Jiangsu Nhwa Pharmaceutical Co., Ltd.· Forrás

• Lezárult

  Efficacy, Safety, and Acceptability of Internet-based Cognitive Behavioral Therapy

  NCT05554289· Adai Technology (Beijing) Co., Ltd.· Forrás

• Lezárult

  Software-delivered CBT-I for Insomnia Disorder

  NCT05747963· Peking University Sixth Hospital· Forrás

• Lezárult

  CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

  NCT04860830· 3. fázis· Boehringer Ingelheim· Forrás